M 58 25
Pill imprint M 58 25 has been identified as Thioridazine hydrochloride 25 mg.
Thioridazine is used in the treatment of schizophrenia and belongs to the drug class phenothiazine antipsychotics. FDA has not classified the drug for risk during pregnancy.
Thioridazine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Thioridazine hydrochloride Images
- Imprint:
-
M 58
25 - Strength:
- 25 mg
- Color:
- Orange
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
FD&C Yellow No. 6
hydroxypropyl cellulose
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- Phenothiazine antipsychotics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0614
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0566 | UDL Laboratories Inc |
| 54868-0067 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Thioridazine Hydrochloride resources
- Thioridazine (Wolters Kluwer)
- Thioridazine Concentrate (Wolters Kluwer)
- thioridazine (Cerner Multum)
- Thioridazine (FDA)
- Thioridazine Hydrochloride (Wolters Kluwer)
Search Again
